Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for partial seizures in infants and young children (1 month to <4 years)
2021-003372-13Phase 3
- Sponsor
- UCB
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by UCB. Primary endpoint: Percent change in partial seizure frequency per week from Baseline to Visit 6.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2021-003372-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003372-13.